Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, a potential ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with ...

Nutriband Inc. through its wholly own subsidiary Pocono Pharma engages in the production of multiple products including AI Tape, which is designed to combine many of the traditional benefits of ...

ORLANDO - Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products with a market capitalization of $74 million, announced Monday that it has received a Notice of ...

The expected issuance of this patent further expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products based on its ...

DeepSeek has rattled the AI industry. Here’s a quick look at other Chinese AI models ...

SOBRsafe (NASDAQ: SOBR) has introduced SOBRsureTM, a wristband that detects alcohol through transdermal technology, offering real-time monitoring fo ...

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

MedPharm, a leader in topical and transdermal contract drug development and manufacturing, has appointed Bill Humphries as ...